Exagen Inc. (XGN)

NASDAQ: XGN · IEX Real-Time Price · USD
8.12 -0.27 (-3.22%)
Jan 21, 2022 4:00 PM EST - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year2020201920182017
Revenue
41.9840.3932.4426.81
Revenue Growth (YoY)
3.93%24.50%21.01%-
Cost of Revenue
16.5618.8115.3814.14
Gross Profit
25.4221.5817.0612.67
Selling, General & Admin
37.0328.719.6818.82
Research & Development
3.572.182.131.55
Other Operating Expenses
000.140.19
Operating Expenses
40.630.8821.9420.56
Operating Income
-15.19-9.3-4.88-7.89
Interest Expense / Income
2.573.492.872.95
Other Expense / Income
-0.98-0.780.2115.35
Pretax Income
-16.77-12.01-7.95-26.18
Income Tax
-0.080.030.06-0.55
Net Income
-16.69-12.04-8.01-25.63
Preferred Dividends
018.2410.477.14
Net Income Common
-16.69-30.28-18.48-32.77
Shares Outstanding (Basic)
13400
Shares Outstanding (Diluted)
13400
Shares Change
252.99%5580.14%0.00%-
EPS (Basic)
-1.32-8.46-293.34-520.18
EPS (Diluted)
-1.32-8.46-293.34-520.18
Free Cash Flow Per Share
-1.15-2.74-150.78-182.18
Gross Margin
60.55%53.43%52.59%47.26%
Operating Margin
-36.18%-23.02%-15.04%-29.42%
Profit Margin
-39.75%-29.81%-24.70%-95.61%
Free Cash Flow Margin
-34.64%-24.30%-29.28%-42.82%
Effective Tax Rate
0.47%-0.21%-0.73%2.10%
EBITDA
-13.66-7.93-4.36-22.56
EBITDA Margin
-32.53%-19.64%-13.42%-84.16%
EBIT
-14.2-8.52-5.09-23.23
EBIT Margin
-33.83%-21.10%-15.68%-86.66%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).